Doceree Enters 2026 as the Only Truly Direct Point-of-Care Engagement Platform at Scale

Why It Matters

Direct EHR integration gives pharma brands measurable, privacy‑compliant reach at the moment of care, unlocking higher ROI than proxy‑based POC solutions. This positions Doceree as a strategic partner as healthcare marketers shift toward data‑driven, workflow‑embedded engagement.

Key Takeaways

• 150+ native EHR integrations enable true in‑workflow engagement
• 2025 saw 50% YoY increase in POC campaign activity
• New Creative Analytics tool optimizes messaging within EHRs
• Direct integration ensures privacy‑safe, first‑party data activation
• Expansion into co‑pay.com adds affordability messaging at point‑of‑care

Pulse Analysis

The healthcare marketing landscape is rapidly converging on point‑of‑care (POC) as the most effective channel for influencing prescribing behavior. Traditional aggregator platforms stitch fragmented EHR access, while consulting or reseller models add layers of latency and dilute data fidelity. Regulators and providers increasingly demand privacy‑safe, first‑party data usage, pushing vendors toward native integration that respects SMART on FHIR interoperability standards. A direct‑to‑EHR approach not only satisfies compliance but also embeds brand messages within the clinician’s decision‑making workflow, dramatically increasing relevance and response rates.

Doceree capitalized on this shift by building an AI‑powered operating system that now connects to more than 150 EHRs, including industry giants Epic and Oracle Cerner. In 2025 the company logged a 50% year‑over‑year surge in POC campaign volume and grew its enterprise client base by 30%, underscoring the market’s appetite for measurable, workflow‑embedded outreach. The launch of Creative Analytics in Q4 added a data‑driven layer that evaluates creative performance directly inside the EHR, giving pharma brands granular insight that proxy models cannot provide. These capabilities translate into higher conversion efficiency and clearer ROI attribution for advertisers.

Looking ahead to 2026, Doceree’s strategy extends beyond pure messaging by integrating co‑pay.com, a tool that surfaces affordability and treatment‑initiation information at the point of decision. Leveraging the same SMART on FHIR framework, the platform can scale compliance‑first campaigns across the entire U.S. provider network while maintaining real‑time contextual intelligence. As competitors scramble to retrofit indirect access, Doceree’s native architecture gives it a defensible moat, likely accelerating adoption among pharma giants seeking predictable, data‑rich POC channels. The industry’s pivot toward AI‑first, directly integrated solutions suggests that platforms like Doceree will set the benchmark for future healthcare advertising.